The pharmaceutical water market comprises products such as pharmaceutical grade water equipment and packaged pharmaceutical water used in various medicinal applications. Pharmaceutical grade water is a type of purified water that meets stringent regulations for content, quality and contamination levels. It is extensively utilized in pharmaceutical manufacturing processes, cleaning of equipment and facilities, rinsing of containers that hold pharmaceutical products and during production.

The global pharmaceutical water market is estimated to be valued at US$ 6.26 Bn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
Strict Regulations: The opportunity for growth in the pharmaceutical water market lies in strict regulations imposed by various regulatory bodies mandating usage of purified water for manufacturing pharmaceutical and medicinal products. Regulatory agencies such as the United States Pharmacopeia (USP), the European Pharmacopoeia (EP), and others have defined stringent quality standards and maximum allowable contaminant levels for water used during production processes. Non-compliance can attract huge penalties and recalls. This has compelled pharmaceutical manufacturers to invest in robust water purification systems along with packaging of pharmaceutical grade water to ensure quality and purity are maintained as prescribed. Growing regulatory oversight is expected to further propel demand over the forecast period.

Porter's Analysis
Threat of new entrants: Low capital requirements and established distribution channels lower barriers to entry. However, stringent regulations and established customer relationships of existing players deter new entrants.

Bargaining power of buyers: Large pharmaceutical companies have significant bargaining power due to bulk purchases. However, need for compliance and specialized technical services limits switching.

Bargaining power of suppliers: Leading technology providers and water treatment firms have some power. However, availability of substitutes and importance of strategic partnerships curb potential for abuse of power.

Threat of new substitutes: No close substitutes exist currently. However, alternative water treatment technologies pose a potential long-term threat.

Competitive rivalry: Intense due to technological expertise, compliance requirements and global presence of major players. Companies compete on quality, reliability and overall project costs.

SWOT Analysis
Strengths: High demand from pharmaceutical and biotech sectors. Stringent regulatory norms ensure steady revenue streams.

Weaknesses: High initial investments and operating costs. Vulnerable to supply chain disruption during health crises.

Opportunities: Growing biosimilars market and developing regions offer scope for expansion. Rising prominence of wastewater recycling presents opportunities.

Threats: Slow drug approvals during pandemics impact production. Threat from local players in price-sensitive emerging markets.

Key Takeaways
The Global Pharmaceutical Water Market Size is expected to witness high growth. It was valued at US$ 6.26 billion in 2023 and is projected to reach US$ 10.39 billion by 2030, registering a CAGR of 7.9% during the forecast period.

Regional analysis
North America currently dominates the market owing to major pharmaceutical manufacturing activity and stringent regulatory environment regarding water quality. The region accounts for around 40% share. However, Asia Pacific is poised to grow at the fastest pace in the coming years led by China, India and other Asian countries expanding their domestic pharmaceutical production capacity and outsourcing from North America and Europe.

Key players
Key players operating in the Pharmaceutical Water Market are Sartorius, Merck KGaA, Thermo Fisher Scientific Inc., GENERAL ELECTRIC, Danaher Corporation, SUEZ Water Technologies & Solutions, Veolia Water Solutions and Technologies, Evoqua Water Technologies LLC, Aqua Solutions, Inc., Baxter International Inc. They offer diverse water treatment systems tailored for applications in small molecule and biopharmaceutical manufacturing. Some focus on turnkey project delivery while others provide individual treatment equipment and aftersales support.


Get more insights on this topic: 

Comments (0)
No login
Login or register to post your comment